• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Insights
  • Challenges Encountered During The Initial Stages Of Exposure Assessment In REACH Registrations

Challenges Encountered During The Initial Stages Of Exposure Assessment In REACH Registrations

Two decades have gone by since the implementation of the EU REACH regulation, and registrants are still facing numerous challenges at every step of exposure assessment, such as collection of key input parameters, description of the lifecycle tree, definition of a strategy, and/or exposure estimation itself.
A scientifically sound rationale is required for the selection of the key input parameters affecting the human health and environmental exposure assessment, including physico-chemical (PC) and environmental fate (Efate) properties, an especially daunting task in the case of complex substances such as UVCBs.
ECHA Guidance Chapter R.12 on building life cycle trees must be understood and followed. Organized and logic lists of uses are key to ease the communication down the supply chain, and some watchouts on tonnage and spERCs selection should be considered to avoid over-estimation of exposure.

READ MORE ON THE PDF

More insights

New Approach Methodologies (NAMs) For Prostaglandin Safety In Cosmetics

Previous thumb

Unravelling the EU's ERA Guidelines for Medicinal Products: What’s in the Box and What’s Still Missing?

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok